108 related articles for article (PubMed ID: 9376194)
1. The effect of onapristone, a progesterone antagonist, on the growth of human gastrointestinal cancer xenografts.
Jacobs E; Watson SA; Ellis IO; Hardcastle JD; Robertson JF
Eur J Cancer; 1997 Jun; 33(7):1130-5. PubMed ID: 9376194
[TBL] [Abstract][Full Text] [Related]
2. The tumour-inhibiting potential of the progesterone antagonist Onapristone in the human mammary carcinoma T61 in nude mice.
Schneider MR; Michna H; Habenicht UF; Nishino Y; Grill HJ; Pollow K
J Cancer Res Clin Oncol; 1992; 118(3):187-9. PubMed ID: 1548283
[TBL] [Abstract][Full Text] [Related]
3. The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death.
Michna H; Schneider MR; Nishino Y; el Etreby MF
J Steroid Biochem; 1989; 34(1-6):447-53. PubMed ID: 2626038
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumours.
Oki E; Sakaguchi Y; Toh Y; Oda S; Maehara Y; Yamamoto N; Sugimachi K
Br J Cancer; 1998 Sep; 78(5):625-30. PubMed ID: 9744503
[TBL] [Abstract][Full Text] [Related]
5. Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer.
Robertson JF; Willsher PC; Winterbottom L; Blamey RW; Thorpe S
Eur J Cancer; 1999 Feb; 35(2):214-8. PubMed ID: 10448262
[TBL] [Abstract][Full Text] [Related]
6. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors.
Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF
Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083
[TBL] [Abstract][Full Text] [Related]
7. Modulation of oestrogenic effects by progesterone antagonists in the rat uterus.
Chwalisz K; Stöckemann K; Fritzemeier KH; Fuhrmann U
Hum Reprod Update; 1998; 4(5):570-83. PubMed ID: 10027611
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.
Huang Y; Hu W; Huang J; Shen F; Sun Y; Ivan C; Pradeep S; Dood R; Haemmerle M; Jiang D; Mangala LS; Noh K; Hansen JM; Dalton HJ; Previs RA; Nagaraja AS; McGuire M; Jennings NB; Broaddus R; Coleman RL; Sood AK
Mol Cancer Ther; 2018 Feb; 17(2):464-473. PubMed ID: 29237804
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
[TBL] [Abstract][Full Text] [Related]
10. Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine.
Watson SA; Wilkinson LJ; Robertson JF; Hardcastle JD
Gut; 1993 Aug; 34(8):1091-6. PubMed ID: 8174960
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors.
Chwalisz K; Hegele-Hartung C; Fritzemeier KH; Beier HM; Elger W
Endocrinology; 1991 Jul; 129(1):312-22. PubMed ID: 2055191
[TBL] [Abstract][Full Text] [Related]
12. Induction of TGF-beta by an antiprogestin in the human breast cancer cell line T-47D.
Dannecker C; Possinger K; Classen S
Ann Oncol; 1996 Apr; 7(4):391-5. PubMed ID: 8805931
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
Cottu PH; Bonneterre J; Varga A; Campone M; Leary A; Floquet A; Berton-Rigaud D; Sablin MP; Lesoin A; Rezai K; Lokiec FM; Lhomme C; Bosq J; Bexon AS; Gilles EM; Proniuk S; Dieras V; Jackson DM; Zukiwski A; Italiano A
PLoS One; 2018; 13(10):e0204973. PubMed ID: 30304013
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours.
Azoitei N; Pusapati GV; Kleger A; Möller P; Küfer R; Genze F; Wagner M; van Lint J; Carmeliet P; Adler G; Seufferlein T
Gut; 2010 Oct; 59(10):1316-30. PubMed ID: 20732914
[TBL] [Abstract][Full Text] [Related]
15. Interactions between oestradiol and danazol on the growth of gastrointestinal tumour cells.
Watson SA; Crosbee DM; Dilks KL; Robertson JF; Hardcastle JD
Anticancer Res; 1993; 13(1):97-102. PubMed ID: 8476232
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth.
Watson SA; Crosbee DM; Morris DL; Robertson JF; Makovec F; Rovati LC; Hardcastle JD
Br J Cancer; 1992 Jun; 65(6):879-83. PubMed ID: 1616859
[TBL] [Abstract][Full Text] [Related]
17. Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II).
Brünner N; Yee D; Kern FG; Spang-Thomsen M; Lippman ME; Cullen KJ
Eur J Cancer; 1993; 29A(4):562-9. PubMed ID: 8435211
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of anticancer agents, growth and chemosensitivity of human tumour xenografts in a segregating stock of AF nude mice.
Maruo K; Emura R; Ohnishi Y; Endo S; Ueyama Y; Nomura T
Lab Anim; 1991 Oct; 25(4):342-7. PubMed ID: 1753695
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen and progesterone receptors in gastrointestinal cancer cell lines.
Jacobs E; Watson SA; Hardcastle JD; Robertson JF
Eur J Cancer; 1996 Dec; 32A(13):2348-53. PubMed ID: 9038620
[TBL] [Abstract][Full Text] [Related]
20. The effect of the E2 prostaglandin enprostil, and the somatostatin analogue SMS 201 995, on the growth of a human gastric cell line, MKN45G.
Watson SA; Durrant LG; Morris DL
Int J Cancer; 1990 Jan; 45(1):90-4. PubMed ID: 2105279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
